Labocanna

Labocanna EBITDA per Share

The EBITDA per Share of Labocanna (LCN.WA) as of Oct 17, 2026 is -0.01 PLN.

EBITDA per Share

-0.01PLN

YoY

84.35%

Last updated:

EBITDA per Share of Labocanna is 2025 -0.01 PLN. EBITDA per Share of Labocanna was 2024 -0.00 PLN. It decreases by 84.35% lower compared to the previous year.

The Labocanna EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2018
-0.07 PLN
Jan 1, 2019
-0.02 PLN
Jan 1, 2020
0.01 PLN
Jan 1, 2021
-0.01 PLN
Jan 1, 2022
-0.01 PLN
Jan 1, 2023
-0.02 PLN
Jan 1, 2024
-0.00 PLN
Jan 1, 2025
-0.01 PLN
The Labocanna EBITDA per Share history
YEAREBITDA per ShareYoY
-0.01PLN+84.35%
-0.00PLN-77.24%
-0.02PLN+220.58%
-0.01PLN-32.20%
-0.01PLN-182.77%
0.01PLN-150.00%
-0.02PLN-67.31%
-0.07PLN+103.92%
-0.03PLN-1.92%
-0.03PLN-180.00%
0.04PLN—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Labocanna Stock analysis

What does Labocanna do? Labocanna SA is a pharmaceutical company based in Koszalin, Poland, operating within the Health Care sector. The company's primary focus is on the hemp business, as indicated by its operational description. It completed its initial public offering (IPO) on July 4, 2011, marking its entry into the public market. Labocanna SA is listed under the ticker symbol LCN.WA and holds the ISIN code PLCCTLS00017. The company's headquarters are located in Koszalin, a city in the West Pomeranian Voivodeship (Woj. Zachodniopomorskie) of Poland. Its official website is https://labocanna.pl/, which serves as a primary source of information about its operations and offerings. The company operates within the pharmaceutical industry, though specific details about its products, services, or market position are not provided in the available information. Labocanna SA's activities are centered around the hemp sector, which may include the development, production, or distribution of hemp-related products, though the exact nature of these activities remains unspecified. The company's public listing and headquarters location are key identifiers for its operational and financial profile. No additional details regarding founding year, key personnel, acquisitions, or financial figures are included in the provided data. Labocanna is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Labocanna stock

EBITDA per Share of Labocanna is -0.01 PLN in 2025.

On Eulerpool you can find the complete historical development of EBITDA per Share Labocanna since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Labocanna

All Key Metrics — Labocanna